SLI Medical Acceptable Dating: we will ship >= 180 days
Storage Requirements
Requires Refrigeration
Strength
10 mg / 2 mL
Type
Intravenous
UNSPSC Code
42161608
Volume
2 mL
Features
Parsabiv® (etelcalcetide) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis
PARSABIV (etelcalcetide) injection is supplied in a single-dose vial (type I glass) with stopper (fluoropolymer laminated elastomeric) and an aluminum seal with flip-off dust cover containing 5 mg/mL of etelcalcetide as a ready-to-use clear and colorless solution